Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription 10.08.2020 2 AJR Am J Roentgenol 1 Ann Surg 8 Ann Thorac Surg 2 Anticancer Res 1 Cancer 2 Cancer Cell 1 Cancer Lett 1 Chest 1 Clin Cancer Res 2 Clin Lung Cancer 3 Eur J Cancer 1 Int J Cancer 6 J Cancer Res Clin Oncol 1 J Nucl Med 2 J Thorac Cardiovasc Surg 5 Lung Cancer 5 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. MENDOZA DP, Heeger A, Mino-Kenudson M, Lanuti M, et al
   Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.
   AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23835.
   PubMed         Abstract available
   
   
2. MORTANI BARBOSA EJ JR, Yang R, Hershman M
   Real World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
   AJR Am J Roentgenol. 2020 Jul 15. doi: 10.2214/AJR.20.23637.
   PubMed         Abstract available
   
   

   
   Ann Surg

3. RAKOVICH G, Urbanowicz R, Issa R, Wang HT, et al
   Minimizing the Risk of Aerosol Contamination During Elective Lung Resection Surgery.
   Ann Surg. 2020;272:e125-e128.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. DUBOIS RL, Raisig E, Stanifer BP
   Gossypiboma Mimicking Fluorodeoxyglucose-avid Lung Nodule.
   Ann Thorac Surg. 2020;109:e403-e405.
   PubMed         Abstract available
   
   
5. UEDA K, Murakami J, Tanaka T, Nakamura T, et al
   Postoperative Complications and Cancer Recurrence: Impact on Poor Prognosis of Lower Lobe Cancer.
   Ann Thorac Surg. 2020;109:1750-1756.
   PubMed         Abstract available
   
   
6. SUN B, Kamel MK, Nasar A, Harrison S, et al
   Staple Line Thickening After Sublobar Resection: Reaction or Recurrence?
   Ann Thorac Surg. 2020;109:1670-1676.
   PubMed         Abstract available
   
   
7. SHIMADA Y, Maehara S, Kudo Y, Masuno R, et al
   Profiles of Lung Adenocarcinoma With Multiple Ground-Glass Opacities and the Fate of Residual Lesions.
   Ann Thorac Surg. 2020;109:1722-1730.
   PubMed         Abstract available
   
   
8. QIAN K, Krimsky WS, Sarkar SA, Deng Y, et al
   Efficiency of Electromagnetic Navigation Bronchoscopy and Virtual Bronchoscopic Navigation.
   Ann Thorac Surg. 2020;109:1731-1740.
   PubMed         Abstract available
   
   
9. RASING MJA, Peters M, Moreno AC, Hofman EFN, et al
   Predicting incomplete resection in non-small cell lung cancer preoperatively: a validated nomogram.
   Ann Thorac Surg. 2020 Jul 30. pii: S0003-4975(20)31222.
   PubMed         Abstract available
   
   
10. JONES GD, Caso R, Choe G, Tan KS, et al
    Intentional Segmentectomy for Clinical T1N0 Non-Small Cell Lung Cancer: Survival Differs by Segment.
    Ann Thorac Surg. 2020 Jul 30. pii: S0003-4975(20)31223.
    PubMed         Abstract available
    
    
11. LOCOCO F, Cusumano G, Cardillo G
    It's Unnecessary to Perform N1-N2 Sampling/dissection in Predominantly-GGO cStage-I Lung Cancer?
    Ann Thorac Surg. 2020 Aug 3. pii: S0003-4975(20)31280.
    PubMed        
    
    

    
    Anticancer Res

12. CAO C, Kong MX, Kapali M, Moezardalan K, et al
    EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
    Anticancer Res. 2020;40:4401-4404.
    PubMed         Abstract available
    
    
13. CZAJKA M, Zajkowska A, Gawlak M, Bujalska-Zadrozny M, et al
    Mosaic Recombinant Adeno-associated Virus Vector rAAV/DJ/CAG for Targeted Gene Delivery to Melanoma Cells Metastasized to the Lung.
    Anticancer Res. 2020;40:4425-4444.
    PubMed         Abstract available
    
    

    
    Cancer

14. ZHANG EW, Dagogo-Jack I, Kuo A, Rooney MM, et al
    Association between circulating tumor DNA burden and disease burden in patients with ALK-positive lung cancer.
    Cancer. 2020 Aug 5. doi: 10.1002/cncr.33118.
    PubMed         Abstract available
    
    

    
    Cancer Cell

15. GOVEIA J, Rohlenova K, Taverna F, Treps L, et al
    An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.
    Cancer Cell. 2020;37:21-36.
    PubMed         Abstract available
    
    
16. KURPPA KJ, Liu Y, To C, Zhang T, et al
    Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
    Cancer Cell. 2020;37:104-122.
    PubMed         Abstract available
    
    

    
    Cancer Lett

17. WANG D, Cong J, Fu B, Zheng X, et al
    Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer.
    Cancer Lett. 2020 Aug 3. pii: S0304-3835(20)30399.
    PubMed         Abstract available
    
    

    
    Chest

18. HOEIJMAKERS F, Heineman DJ, Daniels JM, Beck N, et al
    Variation between multidisciplinary tumor boards in clinical staging and treatment recommendations for patients with locally advanced non-small cell lung cancer.
    Chest. 2020 Jul 29. pii: S0012-3692(20)32079-1. doi: 10.1016/j.chest.2020.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

19. DI FEDERICO A, Filippini DM, Dall'Olio FG, Conci N, et al
    The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter.
    Clin Cancer Res. 2020;26:518-519.
    PubMed        
    
    

    
    Clin Lung Cancer

20. CHANG Q, Xu J, Qiang H, Teng J, et al
    EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study.
    Clin Lung Cancer. 2020 Jul 6. pii: S1525-7304(20)30187.
    PubMed         Abstract available
    
    
21. ELBANNA M, Shiue K, Edwards D, Cerra-Franco A, et al
    Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Clin Lung Cancer. 2020 Jun 2. pii: S1525-7304(20)30164.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

22. SAITO S, Kadota T, Gochi M, Takagi M, et al
    Re-administration of pembrolizumab with prednisolone after pembrolizumab-induced nephrotic syndrome.
    Eur J Cancer. 2020;126:74-77.
    PubMed        
    
    
23. MANKOR JM, Zwierenga F, Dumoulin DW, Neefjes JJC, et al
    A brief report on combination chemotherapy and anti-programmed death (ligand) 1 treatment in small-cell lung cancer: Did we choose the optimal chemotherapy backbone?
    Eur J Cancer. 2020;137:40-44.
    PubMed         Abstract available
    
    
24. PASSIGLIA F, Malapelle U, Del Re M, Righi L, et al
    KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challenges.
    Eur J Cancer. 2020;137:57-68.
    PubMed         Abstract available
    
    

    
    Int J Cancer

25. YOO JE, Han K, Shin DW, Park SH, et al
    Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: a nationwide cohort study.
    Int J Cancer. 2020 Aug 1. doi: 10.1002/ijc.33239.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

26. FRANZESE C, Bonu ML, Comito T, Clerici E, et al
    Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    J Cancer Res Clin Oncol. 2020;146:2289-2297.
    PubMed         Abstract available
    
    
27. KASHIWABARA K, Fujii S, Tsumura S, Sakamoto K, et al
    Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study.
    J Cancer Res Clin Oncol. 2020 Aug 6. pii: 10.1007/s00432-020-03344.
    PubMed         Abstract available
    
    
28. ZHOU X, Xu X, Tian Z, Xu WY, et al
    Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing.
    J Cancer Res Clin Oncol. 2020;146:2277-2287.
    PubMed         Abstract available
    
    
29. LIU J, Yang X, Zhang L, Yang B, et al
    Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2020;146:2299-2310.
    PubMed         Abstract available
    
    
30. KIM SA, Kim JW, Suh KJ, Chang W, et al
    Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases.
    J Cancer Res Clin Oncol. 2020;146:2399-2410.
    PubMed         Abstract available
    
    
31. ZHANG Y, Deng C, Ma X, Gao Z, et al
    Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
    J Cancer Res Clin Oncol. 2020;146:2411-2417.
    PubMed         Abstract available
    
    

    
    J Nucl Med

32. JREIGE M, Dunet V, Letovanec I, Prior JO, et al
    Pulmonary lymphangitic carcinomatosis: diagnostic performance of HRCT and (18)F-FDG-PET/CT in correlation to clinical pathologic outcome.
    J Nucl Med. 2019 Jun 21. pii: jnumed.119.229575. doi: 10.2967/jnumed.119.229575.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

33. FAN L, Yang H, Yu L, Wang Z, et al
    Multicenter, prospective, observational study of a novel technique for preoperative pulmonary nodule localization.
    J Thorac Cardiovasc Surg. 2020;160:532-539.
    PubMed         Abstract available
    
    
34. NELSON DB, Antonoff MB
    Commentary: The prognostic value of Kirsten rat sarcoma viral oncogene mutation for non-small cell lung cancer: One size does not always fit all.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31990.
    PubMed        
    
    

    
    Lung Cancer

35. FAN Y, Chen J, Zhou C, Wang H, et al
    Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial.
    Lung Cancer. 2020;147:209-213.
    PubMed         Abstract available
    
    
36. YOUNG K, Jiang H, Marquez M, Yeung J, et al
    Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipients.
    Lung Cancer. 2020;147:214-220.
    PubMed         Abstract available
    
    
37. YANG G, Xu H, Yang L, Xu F, et al
    Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study.
    Lung Cancer. 2020;147:229-236.
    PubMed         Abstract available
    
    
38. ROJO F, Corassa M, Mavroudis D, Oz AB, et al
    International real-world study of DLL3 expression in patients with small cell lung cancer.
    Lung Cancer. 2020;147:237-243.
    PubMed         Abstract available
    
    
39. VAD-NIELSEN J, Meldgaard P, Sorensen BS, Nielsen AL, et al
    Cell-free Chromatin Immunoprecipitation (cfChIP) from blood plasma can determine gene-expression in tumors from non-small-cell lung cancer patients.
    Lung Cancer. 2020;147:244-251.
    PubMed         Abstract available
    
    

    
    PLoS One

40. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    PubMed         Abstract available
    
    
41. ARIK A, Dodd E, Streftaris G
    Cancer morbidity trends and regional differences in England-A Bayesian analysis.
    PLoS One. 2020;15:e0232844.
    PubMed         Abstract available
    
    
42. QIAN C, Liu H, Feng Y, Meng S, et al
    Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
    PLoS One. 2020;15:e0231807.
    PubMed         Abstract available
    
    
43. FORSYTHE ML, Alwithenani A, Bethune D, Castonguay M, et al
    Molecular profiling of non-small cell lung cancer.
    PLoS One. 2020;15:e0236580.
    PubMed         Abstract available
    
    
44. 
    Retraction: Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection.
    PLoS One. 2020;15:e0237589.
    PubMed        
    
    

    
    Thorax

45. RUPAREL M, Quaife SL, Dickson JL, Horst C, et al
    Lung Screen Uptake Trial: results from a single lung cancer screening round.
    Thorax. 2020 Aug 5. pii: thoraxjnl-2020-214703.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: